LifeTech Scientific Corporation (HKG:1302)

LifeTech Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	953.77	719.32	665.76	979.31	833.79	1,119
Short-Term Investments	139.31	29.78	205.13	80	-	158.11
Trading Asset Securities	143	401	311	120	-	199
Cash & Short-Term Investments	1,236	1,150	1,182	1,179	833.79	1,476
Cash Growth	-11.39%	-2.69%	0.22%	41.44%	-43.52%	29.20%
Accounts Receivable	122.03	161.8	136.69	105.19	137.09	110.04
Other Receivables	138.65	444.53	95.42	78.62	78.45	51.92
Receivables	260.67	606.33	232.11	183.81	215.54	161.96
Inventory	421.97	444.9	532.4	483.61	241.41	129.29
Other Current Assets	151.58	123.81	387.78	384.42	105.92	69.45
Total Current Assets	2,070	2,325	2,334	2,231	1,397	1,837
Property, Plant & Equipment	955.15	968.51	976.5	884.86	783.39	724.07
Long-Term Investments	486.13	505.53	421.94	531.71	725.5	48.63
Other Intangible Assets	800.49	190.38	70.25	75.15	84.42	76.07
Long-Term Deferred Tax Assets	133.24	125.58	117.14	83.03	62.6	47
Long-Term Deferred Charges	-	588.81	660.41	581.52	357.99	288.76
Other Long-Term Assets	304.06	308.5	319.96	308.95	279.56	162.12
Total Assets	4,749	5,012	4,900	4,696	3,690	3,184

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	540.34	84.7	59.54	124.09	62.65	30.76
Accrued Expenses	248.6	276.89	283.67	284.58	290.88	237.14
Current Portion of Leases	4.07	3.76	3.79	6.29	5.04	11.05
Current Income Taxes Payable	37.39	26.55	32.2	45.94	37.82	34.03
Current Unearned Revenue	9.45	34.57	26.09	12.5	13.17	11.43
Other Current Liabilities	-	1,053	410.34	296.74	175.18	157.51
Total Current Liabilities	844.85	1,479	815.64	770.14	584.74	481.91
Long-Term Leases	5.03	4.28	1.19	3	4.64	4.63
Long-Term Unearned Revenue	54.17	53.64	49.79	40.93	37.17	32.08
Other Long-Term Liabilities	576.78	-	558.33	558.33	142.5	135
Total Liabilities	1,481	1,537	1,425	1,372	769.05	653.61

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.04	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	-	1,544	1,632	1,643	1,628	1,621
Retained Earnings	-	2,073	1,925	1,702	1,439	1,114
Comprehensive Income & Other	3,319	-103.63	-62.85	24.94	-166.88	-231.38
Total Common Equity	3,319	3,513	3,495	3,370	2,900	2,504
Minority Interest	-50.84	-37.54	-19.08	-46.27	20.61	26.52
Shareholders' Equity	3,269	3,475	3,475	3,324	2,921	2,530
Total Liabilities & Equity	4,749	5,012	4,900	4,696	3,690	3,184

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	14.1	8.04	4.98	9.3	9.67	15.67
Net Cash (Debt)	1,222	1,142	1,177	1,170	824.12	1,461
Net Cash Growth	-12.16%	-2.96%	0.59%	41.97%	-43.58%	52.68%
Net Cash Per Share	0.27	0.26	0.27	0.26	0.19	0.32
Filing Date Shares Outstanding	4,632	4,632	4,631	4,630	4,630	4,630
Total Common Shares Outstanding	4,632	4,632	4,631	4,630	4,630	4,630
Working Capital	1,225	845.73	1,519	1,461	811.92	1,355
Book Value Per Share	0.72	0.76	0.75	0.73	0.63	0.54
Tangible Book Value	2,519	3,322	3,424	3,295	2,816	2,428
Tangible Book Value Per Share	0.54	0.72	0.74	0.71	0.61	0.52
Buildings	-	828.33	708.42	641.54	560.72	198.81
Machinery	-	383.76	337.97	306.4	262.72	265.59
Construction In Progress	-	8.92	122.79	76.04	55.31	325.06
Leasehold Improvements	-	37.75	33.62	30.57	28.61	20.44

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 12, 2026

Data Sources Report a data error